Afrigen

Latest

Governance
A production scientist works with samples during a visit by representatives of the Medicines Patent Pool, France and other European Union member states, at the Afrigen Biologics' site in Cape Town, South Africa, February 3, 2022.

In Africa, Open Biologics and Tech Transfer Pave the Way for Local Vaccine Manufacturing

by Aggrey Aluso

How the development of Africa's first home-grown mRNA COVID-19 vaccine could shape the future of vaccine innovation